Cargando…
Permanent neonatal diabetes mellitus in China
BACKGROUND: Permanent neonatal diabetes mellitus (PNDM) is a rare disease, which is defined as the onset of diabetes before the age of 6 months with persistence through life. Infants with KCNJ11 or ABCC8 genetic mutations may respond to oral sulfonylurea therapy. Currently, there are limited studies...
Autores principales: | Huang, Ke, Liang, Li, Fu, Jun-feng, Dong, Guan-pin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118223/ https://www.ncbi.nlm.nih.gov/pubmed/25052923 http://dx.doi.org/10.1186/1471-2431-14-188 |
Ejemplares similares
-
Permanent neonatal diabetes mellitus in China
por: Huang, Ke, et al.
Publicado: (2015) -
Permanent neonatal diabetes mellitus
por: Al-Matary, Abdulrahman, et al.
Publicado: (2012) -
Meglitinide (repaglinide) therapy in permanent neonatal diabetes mellitus: two case reports
por: Razzaghy-Azar, Maryam, et al.
Publicado: (2021) -
Successful sulfonylurea treatment in a patient with permanent neonatal diabetes mellitus with a novel KCNJ11 mutation
por: Ahn, Sung Yeon, et al.
Publicado: (2015) -
Permanent Neonatal Diabetes Mellitus: Same Mutation, Different Glycemic Control with Sulfonylurea Therapy on Long-Term Follow-up
por: Küçükemre Ay, Banu, et al.
Publicado: (2012)